Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
54.21
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EST, Jan 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
34
35
Next >
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
↗
December 29, 2022
These two biotechs are flying high right now.
Via
The Motley Fool
5 Unstoppable Trends to Invest $5,000 in for 2023
↗
December 29, 2022
These trends won't fade away, and some of the companies that are positioned to ride them should be big winners.
Via
The Motley Fool
Could CRISPR Therapeutics Help You Become a Millionaire?
↗
December 27, 2022
The gene-editing stock still has plenty of promise.
Via
The Motley Fool
Is Vertex Pharmaceuticals a Buy?
↗
December 27, 2022
There's more growth ahead for this biotech giant.
Via
The Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
↗
December 24, 2022
This company has had a solid year, but there is still plenty of work ahead.
Via
The Motley Fool
Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?
↗
December 22, 2022
Crispr and Vertex are working toward the first submissions for a CRISPR-based product.
Via
Investor's Business Daily
What 5 Analyst Ratings Have To Say About CRISPR Therapeutics
↗
November 23, 2022
Via
Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
↗
December 22, 2022
Vertex Therapeutics and Amgen have the building blocks for long-term success.
Via
The Motley Fool
3 Cathie Wood Stocks That Could Make Big Comebacks in 2023
↗
December 22, 2022
These businesses aren't in as much trouble as their stock returns suggest that they are.
Via
The Motley Fool
3 Growth Stocks That Are Screaming Buys in December
↗
December 21, 2022
Don't let these companies pass you by the next time you go stock shopping.
Via
The Motley Fool
Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock
↗
December 18, 2022
Both stocks are heading for double-digit gains this year.
Via
The Motley Fool
3 Beaten-Down Stocks That Could Explode Higher in 2023
↗
December 17, 2022
These stocks could have significant upside opportunities ahead.
Via
The Motley Fool
7 Stocks to Add to Your 10x Watchlist
↗
December 16, 2022
It’s always a good time to look for stocks with exceptional growth potential. Here are seven 10x stocks for your watchlist.
Via
InvestorPlace
3 Growth Stocks With More Potential Than Any Cryptocurrency
↗
December 15, 2022
If the crypto meltdown has you discouraged, don't give up on stocks.
Via
The Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
↗
December 11, 2022
The success these stocks achieved in 2022 could be just the beginning.
Via
The Motley Fool
Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition
December 10, 2022
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Want to Be Ready For a New Bull Market? Do These 3 Things Soon
↗
December 09, 2022
It's easier to make money in bull markets when you've done the prep work beforehand.
Via
The Motley Fool
2 Growth Stocks That Could Help Set You Up for Life
↗
December 09, 2022
Many growth stocks are down, but they're not all out.
Via
The Motley Fool
5 Best Bargain Stocks to Buy Before 2023
↗
December 09, 2022
It's time to hit the best sale in town, and that involves many top stocks.
Via
The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
↗
December 08, 2022
The three companies are changing the pharmaceutical industry.
Via
The Motley Fool
Is CRISPR Therapeutics a Buy?
↗
December 08, 2022
A strong cash position could offset some of the near-term risks that come with owning the biotech.
Via
The Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
↗
December 08, 2022
-Clinical Data Due Next Week at ASH-
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
↗
December 08, 2022
These biotech players beat the bear market this year.
Via
The Motley Fool
3 Fierce Stocks That Are Screaming Buys in December
↗
December 07, 2022
Here are three winners in the making.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
↗
December 06, 2022
The company has already made plenty of investors happy.
Via
The Motley Fool
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
↗
December 06, 2022
These top players are ripe for recovery -- and long-term growth.
Via
The Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
↗
December 01, 2022
Overlooking these stocks in the current market could be a mistake.
Via
The Motley Fool
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
↗
November 28, 2022
Here's how Ark Invest's top holdings have performed in 2022.
Via
Investor's Business Daily
2 Stocks Near 52-Week Highs That Could Climb Higher
↗
November 28, 2022
This pair of stocks are bucking the trend and they could climb even higher.
Via
The Motley Fool
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
↗
November 25, 2022
The ARK Invest founder might regret trimming her position in this biotech stock.
Via
The Motley Fool
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
